{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:47:05Z","timestamp":1791924425494,"version":"4.3.4"},"reference-count":0,"publisher":"Medical Journals Sweden AB","issue":"7","content-domain":{"domain":["www.medicaljournals.se"],"crossmark-restriction":true},"short-container-title":["Acta Derm Venerol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.2340\/00015555-3168","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T13:13:22Z","timestamp":1552050802000},"page":"677-678","update-policy":"https:\/\/doi.org\/10.2340\/adv_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Morbihan Syndrome Successfully Treated with Omalizumab"],"prefix":"10.2340","volume":"99","author":[{"given":"P","family":"Kafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Ed\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Swartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","container-title":["Acta Dermato Venereologica"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:15:00Z","timestamp":1675761300000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/3228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.2340\/00015555-3168","relation":{},"ISSN":["0001-5555"],"issn-type":[{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}